Used primarily as an active pharmaceutical ingredient in nonsteroidal anti-inflammatory drugs (NSAIDs), this compound, known as (S)-naproxen, exhibits potent anti-inflammatory, analgesic, and antipyretic properties. It is commonly employed in the treatment of chronic inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Due to its selective inhibition of cyclooxygenase-2 (COX-2) enzyme activity, it helps reduce inflammation and pain with a potentially lower risk of gastrointestinal side effects compared to non-selective NSAIDs. Its (S)-enantiomer configuration is crucial for optimal pharmacological activity, as it demonstrates higher potency and target specificity. The compound is formulated in oral dosage forms and is valued for its sustained therapeutic effect and favorable pharmacokinetic profile in long-term management of pain and inflammation.